Authors: MERISKOLIVERSIDGE E SARPOTDAR P BRUNO J HAJJ S WEI L PELTIER N RAKE J SHAW JM PUGH S POLIN L JONES J CORBETT T COOPER E LIVERSIDGE GG

Citation: E. Meriskoliversidge et al., FORMULATION AND ANTITUMOR-ACTIVITY EVALUATION OF NANOCRYSTALLINE SUSPENSIONS OF POORLY SOLUBLE ANTICANCER DRUGS, Pharmaceutical research, 13(2), 1996, pp. 272-278

Authors: MERISKOLIVERSIDGE E SHAW MJ MCINTIRE G SARPOTDAR P COOPER E WOLF G CORBETT T LIVERSIDGE GG

Citation: E. Meriskoliversidge et al., NANOPARTICLES IN DRUG-DELIVERY, Journal of cellular biochemistry, 1995, pp. 168-168

Authors: HUFF BV LIVERSIDGE GG MCINTIRE GL

Citation: Bv. Huff et al., THE ELECTROPHORETIC MOBILITY OF TRIPEPTIDES AS A FUNCTION OF PH AND IONIC-STRENGTH - COMPARISON WITH IONTOPHORETIC FLUX DATA, Pharmaceutical research, 12(5), 1995, pp. 751-755

Authors: LIVERSIDGE GG CONZENTINO P

Citation: Gg. Liversidge et P. Conzentino, DRUG PARTICLE-SIZE REDUCTION FOR DECREASING GASTRIC IRRITANCY AND ENHANCING ABSORPTION OF NAPROXEN IN RATS, International journal of pharmaceutics, 125(2), 1995, pp. 309-313

Authors: LIVERSIDGE GG CUNDY KC

Citation: Gg. Liversidge et Kc. Cundy, PARTICLE-SIZE REDUCTION FOR IMPROVEMENT OF ORAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS .1. ABSOLUTE ORAL BIOAVAILABILITY OF NANOCRYSTALLINE DANAZOL IN BEAGLE DOGS, International journal of pharmaceutics, 125(1), 1995, pp. 91-97